Bioceres Crop Solutions Corp. (BIOX) Form 6-K — Nov 17, 2026
Bioceres Crop Solutions (NASDAQ: BIOX) reported fiscal first quarter 2027 revenue of $53.8 million, down 22% year-over-year, driven by phasing in soybean-related products and a more competitive adjuvant and nutrition market in Argentina. Net loss from continuing operations widened 127% to $10.8 million from $4.7 million a year ago, while Adjusted EBITDA fell 62% to $5.3 million — though it marked a second consecutive quarter of sequential improvement.
Key figures
- Revenue
- 53800000
- Total Debt
- 221700000
- Gross Profit
- 18800000
- Cash Position
- 8700000
- Sga
- $17.4 million
- Rd expense
- $1.8 million (down 51%)
- Gross margin
- 35.0% (down from 44.5%)
- Total equity
- $23.4 million (down from $34.1M at 6/30/2026)
- Adjusted ebitda
- $5.3 million (down 62% from $13.9M in 1Q26)
- Net financial debt
- $213.0 million
- Crop nutrition revenue
- $18.8 million (-20%)
- Crop protection revenue
- $29.1 million (-12%)
- Seed integrated revenue
- $5.9 million (-53%)
- Secured notes short term
- $112.0 million
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.